Key facts
- This page summarizes William Guyer's Form 4 filing for CORCEPT THERAPEUTICS INC (CORT).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 03 Sep 2021, 17:12.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Award
Additional SEC filing notes
Footnote F1
Shares subject to the stock option vest and become exercisable with respect to 25% of the shares on the first anniversary of August 16, 2021 (the "Vesting Commencement Date") with the remaining shares vesting and becoming exercisable ratably on a monthly basis over a period of 36 consecutive months thereafter until fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service.